SAFETY COMPARISON OF 12- AND 24-WEEK TREATMENTS IN HCV GENOTYPE 1-INFECTED PATIENTS WITH CIRRHOSIS: RESULTS FROM TURQUOISE-II

Heiner Wedemeyer  1     Xavier Forns  2     Antonio Craxi  3     Paul Kwo  4     Stefan Bourgeois  5     Michael Bennett  6     Stephen Ryder     Dominique Larrey     David Mutimer     Sandra Lovell     Manal Abunimeh     Marcos Pedrosa     Roger Trinh    
1 Medizinische Hochschule Hannover, Hannover, Germany
2 Liver Unit, Hospital Clinic, Idibaps, Ciberehd, Barcelona, Spain
3 A.o.u Policlinico "p. Giaccone" Dip. Di Gastroenterologia Ed Epatologia D.b.m.i.s., Palermo, Italy
4 Indiana University, Indianapolis, United States
5 Zna Stuivenberg, Antwerpen, Belgium
6 Medical Associates Research

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing